Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
Arthritis Research & Therapy|April 16, 2021
Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.Scientific Reports|January 16, 2021
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung diseaseShogo Matsuda, Takuya Kotani, Takayasu Suzuka, et al.Rheumatology International|April 27, 2021
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective studyYuichi Maeda, Toru Hirano, Kosuke Ebina, et al.Arthritis Research & Therapy|December 20, 2024
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.Modern Rheumatology|May 10, 2024
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.Modern Rheumatology|June 26, 2026
Risk factors and the effect of belimumab on flares during glucocorticoid tapering in systemic lupus erythematosus: A multicentre ANSWER-SLE cohort studyHirofumi Miyake, Akira Onishi, Hideaki Tsuji, et al.Modern Rheumatology|June 9, 2025
Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort studyHirofumi Miyake, Takuya Kotani, Shogo Matsuda, et al.Frontiers in Immunology|April 20, 2026
Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Muneyuki Hatta, et al.Rheumatology International|July 31, 2020
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.Modern Rheumatology|April 2, 2024
Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort studyAtsushi Manabe, Keiichiro Kadoba, Ryosuke Hiwa, et al.Pageof 11